Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06555289 · ClinicalTrials.gov registry record
Outcomes of Clareon PanOptix Pro in Patients With Prior Myopic Refractive Surgery
A clinical trial of Cataract, sponsored by Juliette Eye Institute Research Center.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT06555289: Recruiting study of Cataract, sponsored by Juliette Eye Institute Research Center.
NCT06555289 is a study of Cataract that is actively recruiting participants, run by Juliette Eye Institute Research Center. The registered enrollment target is 40 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06555289, a study of Cataract, is actively recruiting participants, sponsored by Juliette Eye Institute Research Center.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a Single center, single arm, prospective, observational study of clinical outcomes following bilateral cataract surgery and Clareon PanOptix Pro implantation. Subjects will be assessed preoperatively, and at 1 and 3 months postoperatively. Clinical evaluations will include administration of the QUVID and IOLSAT questionnaires, manifest refraction, topography, as well as measurement of visual acuities at distance, intermediate, and near.
Conditions Studied
Interventions
- DEVICE Clareon PanOptix Pro IOL
Study Locations (1)
New Mexico
- Juliette Eye Institute Research Center - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-10-23 |
| Est. Completion | 2026-09-01 |
What NCT06555289 shows while recruiting
NCT06555289 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which Clareon PanOptix Pro IOL is the first listed.
NCT06555289 reports a single indexed study location in New Mexico.
Frequently Asked Questions
What is clinical trial NCT06555289 about?
NCT06555289 is a clinical study titled "Outcomes of Clareon PanOptix Pro in Patients With Prior Myopic Refractive Surgery". This study is a Single center, single arm, prospective, observational study of clinical outcomes following bilateral cataract surgery and Clareon PanOptix Pro implantation. Subjects will be assessed preoperatively, and at 1 and 3 months postoperatively. Clinical evaluations will include administrati...
What is the current status of trial NCT06555289?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2024-10-23. Estimated completion is 2026-09-01.
What conditions does trial NCT06555289 study?
This clinical trial studies the following conditions: Cataract.
What interventions are being tested in trial NCT06555289?
The interventions under investigation include: Clareon PanOptix Pro IOL (DEVICE).
Who is sponsoring clinical trial NCT06555289?
This trial is sponsored by Juliette Eye Institute Research Center, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06555289 being conducted?
This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06555289's enrollment target sits among peer trials
40 65th of 83 higher than 14 of 83 other Cataract trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cataract trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Intraocular Lens Power Calculation After Laser Refractive Surgery Based on Optical Coherence Tomography
RECRUITING
-
Effective Phaco Time and Endothelial Cell Loss When Using Veritas
RECRUITING
-
Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety and Workflow Study
RECRUITING · NA
-
Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOC
RECRUITING · Phase 1
-
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
RECRUITING · Phase 3
-
Unity VCS: A Comparison Study Evaluating Corneal Clarity and Thickness
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI